We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
The CMA has found that NortonLifeLock’s approximately £6bn purchase of Avast raises competition concerns and may now be referred for an in-depth investigation.
The CMA has provisionally cleared the anticipated acquisition of Avast by NortonLifeLock following an in-depth merger investigation.
The CMA has cleared the anticipated acquisition of Avast by NortonLifeLock following an in-depth merger investigation.
Unprecedented decision reflects the serious impact of Norton’s refusal to provide information.
The Antivirals Taskforce will identify treatments for UK patients who have been exposed to COVID-19 to stop the infection spreading and speed up recovery time.
The CMA has secured extended refund rights for all customers of anti-virus firm Norton whose contracts auto-renew, just weeks after McAfee made a similar commitment.
Thousands of those most at-risk to COVID-19 will soon be able to access the UK’s second ground-breaking antiviral
Following CMA action, McAfee, a leading supplier of anti-virus software, has extended its refund rights for all customers whose contracts have auto-renewed.
Thousands more vulnerable people are eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study.
The public are being urged to sign up to a world-leading study for antivirals if they test positive for COVID-19.
Over 5,000 people have now enrolled in a world-class study for COVID-19 antivirals, meaning thousands of people have accessed the medicines
Security minister warns against IT scams that see fake anti-virus software sold to steal personal information.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Fatal cases of tumour lysis syndrome (TLS) have been reported, some occurring in patients with chronic lymphocytic leukaemia receiving the lowest venetoclax dose used in the dose-titration schedule. For all patients, it is important to strictly adhere to the dose-titration...
Outline of the safety experience of these medicines in the UK from our proactive safety monitoring strategy.
The CMA has today announced a package of reforms to tackle the substantial loyalty penalty impacting millions of people.
Employment Tribunal decision.
A pooled analysis has shown an increased rate of new primary malignancies in patients given Xgeva (1-year cumulative incidence 1.1%) compared with those given zoledronic acid (0.6%), when used in the indication of the prevention of skeletal-related events with advanced...
OFT closed case: Anticipated acquisition by Safenet Inc of nCipher plc.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).